Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Luis Alfonso Rojas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9218-4086; OpenAlex author ID A5067346260. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 6

  1. Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial. Co-author DOI 10.1038/s41591-026-04705-y↗
  2. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08426-5↗
  3. RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer. Co-author DOI 10.1038/s41586-024-08508-4↗
  4. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Co-author DOI 10.1038/s41586-023-06063-y↗
  5. Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Co-author DOI 10.1038/s41586-022-04735-9↗
  6. Scaling the immune incline in PDAC. Co-author DOI 10.1038/s41575-021-00475-9↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vinod P. Balachandran · 4 shared papers, 2021–2025 · strength 0.70
  2. Benjamin D. Greenbaum · 3 shared papers, 2022–2025 · strength 0.42
  3. Taha Merghoub · 3 shared papers, 2022–2025 · strength 0.42
  4. Zachary M. Sethna · 3 shared papers, 2022–2025 · strength 0.42
  5. Kevin C. Soares · 3 shared papers, 2022–2025 · strength 0.42
  6. Masataka Amisaki · 3 shared papers, 2022–2025 · strength 0.42
  7. Akihiro Ohmoto · 2 shared papers, 2025 · strength 0.32
  8. Jedd D. Wolchok · 2 shared papers, 2022–2025 · strength 0.25
  9. Rocio García‐Carbonero · 1 shared paper, 2026 · strength 0.21
  10. Edward Jae-Hoon Kim · 1 shared paper, 2026 · strength 0.21
  11. Chris Nevala-Plagemann · 1 shared paper, 2026 · strength 0.21
  12. Roberto Pazo-Cid · 1 shared paper, 2026 · strength 0.21
  13. Manuel M. Hidalgo · 1 shared paper, 2026 · strength 0.21
  14. Carmen Guillén‐Ponce · 1 shared paper, 2026 · strength 0.21
  15. Eva Martínez de Castro · 1 shared paper, 2026 · strength 0.21
  16. Teresa Mercade Macarulla · 1 shared paper, 2026 · strength 0.21
  17. Olca Baştürk · 1 shared paper, 2025 · strength 0.15
  18. Ryan Sugarman · 1 shared paper, 2025 · strength 0.15
  19. Anna M. Varghese · 1 shared paper, 2025 · strength 0.15
  20. Özlem Türeci · 1 shared paper, 2025 · strength 0.15
  21. T. Peter Kingham · 1 shared paper, 2025 · strength 0.15
  22. Michael Ian D'Angelica · 1 shared paper, 2025 · strength 0.15
  23. Ira Mellman · 1 shared paper, 2025 · strength 0.15
  24. Wungki Park · 1 shared paper, 2025 · strength 0.15
  25. Eileen Mary O'Reilly · 1 shared paper, 2025 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.